Insider Shareholders with Direct Ownership of Incyte Corp (INCY)
This section provides a comprehensive overview of the insiders with direct ownership of Incyte Corp (INCY). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
INCYTE CORP Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Herve Hoppenot
Chairman / CEO |
362,234 | 128,976 | 563,573 $34.1 Million | 16 |
Apr 01, 2025
Added 10.61%
|
| 440,282 | 0 | 281,190 $17 Million | 1 |
Jun 06, 2019
Added 43.91%
|
|
|
Pablo J Cagnoni
President, R&D |
209,132 | 749 | 221,170 $13.4 Million | 4 |
Jul 15, 2024
Reduced 0.34%
|
|
Christiana Stamoulis
EVP & Chief Financial Officer |
129,864 | 23,156 | 129,093 $7.82 Million | 21 |
Apr 01, 2025
Added 12.81%
|
|
Steven H Stein
EVP & Chief Medical Officer |
184,477 | 154,813 | 125,132 $7.58 Million | 27 |
Apr 01, 2025
Added 14.35%
|
|
Paula J Swain
EVP, Human Resources |
100,828 | 46,265 | 107,344 $6.5 Million | 23 |
Apr 01, 2025
Added 9.28%
|
|
Yao Wenqing
EVP, Head of Discovery Chem |
42,152 | 74,903 | 98,575 $5.97 Million | 9 |
Jul 06, 2021
Reduced 0.41%
|
|
Michael James Morrissey
EVP, Head of Tech. Operations |
60,576 | 22,969 | 86,164 $5.22 Million | 24 |
Apr 01, 2025
Added 5.12%
|
|
Maria E Pasquale
EVP & General Counsel |
118,237 | 77,035 | 69,724 $4.22 Million | 27 |
Jul 14, 2023
Added 12.18%
|
|
Barry P Flannelly
EVP & General Manager US |
169,177 | 150,937 | 59,702 $3.61 Million | 32 |
Apr 01, 2025
Added 20.05%
|
|
Dashyant Dhanak
EVP & Chief Scientific Officer |
55,228 | 24,270 | 58,968 $3.57 Million | 31 |
Jul 14, 2023
Added 12.02%
|
|
Vijay K Iyengar
EVP, GMAPPS |
105,265 | 79,869 | 52,799 $3.2 Million | 27 |
Apr 01, 2025
Added 17.22%
|
|
Mohamed Khairie Issa
EVP, Head of US Oncology |
48,671 | 0 | 48,671 $2.95 Million | 1 |
Jan 06, 2025
Added 50.0%
|
|
Jonathan Elliott Dickinson
EVP, General Manager, Europe |
30,608 | 17,457 | 36,390 $2.2 Million | 21 |
Sep 12, 2024
Reduced 16.77%
|
|
Lee Heeson
EVP, Head of Incyte Intl |
32,778 | 0 | 32,778 $1.98 Million | 2 |
Jan 31, 2025
Added 16.19%
|
|
Paul Trower
Principal Accounting Officer |
16,767 | 9,190 | 32,268 $1.95 Million | 6 |
Jan 03, 2022
Reduced 4.15%
|
|
Sheila A. Denton
EVP & General Counsel |
42,652 | 16,804 | 25,848 $1.57 Million | 7 |
Mar 04, 2025
Reduced 2.26%
|
|
Thomas Tray
Principal Accounting Officer |
18,070 | 11,865 | 23,312 $1.41 Million | 18 |
Dec 16, 2024
Reduced 2.71%
|
|
Paul J Clancy
Director |
15,816 | 0 | 20,071 $1.22 Million | 23 |
Mar 31, 2025
Added 1.75%
|
|
Jean Jacques Bienaime
Director |
9,931 | 798 | 18,323 $1.11 Million | 7 |
Jun 12, 2024
Added 13.38%
|
|
Wendy L Dixon
Director |
23,525 | 20,000 | 17,768 $1.08 Million | 10 |
Mar 31, 2022
Added 1.38%
|
|
Edmund Harrigan
Director |
15,336 | 0 | 17,434 $1.06 Million | 24 |
Mar 31, 2025
Added 2.04%
|
|
Jacqualyn A Fouse
Director |
12,005 | 0 | 16,808 $1.02 Million | 14 |
Jun 12, 2024
Added 14.41%
|
|
Katherine A High
Director |
9,402 | 0 | 10,823 $655,332 | 4 |
Jun 12, 2024
Added 20.73%
|
|
Matteo Trotta
EVP, GM, Dermatology US |
10,474 | 537 | 9,937 $601,685 | 3 |
Mar 25, 2025
Reduced 5.13%
|
|
Otis W Brawley
Director |
8,734 | 0 | 8,734 $528,843 | 4 |
Jun 12, 2024
Added 24.47%
|
|
Susanne Schaffert
Director |
6,960 | 1,240 | 5,720 $346,346 | 5 |
Jun 12, 2024
Added 33.1%
|